Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.

Gill SS, Anderson GM, Fischer HD, Bell CM, Li P, Normand SL, Rochon PA.

Arch Intern Med. 2009 May 11;169(9):867-73. doi: 10.1001/archinternmed.2009.43.

PMID:
19433698
3.

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.

Park-Wyllie LY, Mamdani MM, Li P, Gill SS, Laupacis A, Juurlink DN.

PLoS Med. 2009 Sep;6(9):e1000157. doi: 10.1371/journal.pmed.1000157.

4.

Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.

Hutson JR, Fischer HD, Wang X, Gruneir A, Daneman N, Gill SS, Rochon PA, Anderson GM.

Drugs Aging. 2012 Mar 1;29(3):205-11. doi: 10.2165/11599090-000000000-00000.

PMID:
22372724
5.

Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.

Stephenson A, Seitz DP, Fischer HD, Gruneir A, Bell CM, Gershon AS, Fu L, Anderson GM, Austin PC, Rochon PA, Gill SS.

Drugs Aging. 2012 Mar 1;29(3):213-23. doi: 10.2165/11599480-000000000-00000.

PMID:
22332932
6.

Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.

Seitz DP, Gill SS, Gruneir A, Austin PC, Anderson G, Reimer CL, Rochon PA.

Am J Geriatr Psychiatry. 2011 Sep;19(9):803-13. doi: 10.1097/JGP.0b013e3181ff67a1.

PMID:
21873836
7.

Syncope with cholinesterase inhibitors.

[No authors listed]

Prescrire Int. 2011 Oct;20(120):240.

PMID:
21970087
8.

Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.

Hernandez RK, Farwell W, Cantor MD, Lawler EV.

J Am Geriatr Soc. 2009 Nov;57(11):1997-2003. doi: 10.1111/j.1532-5415.2009.02488.x.

PMID:
19793162
9.

Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.

Kim DH, Brown RT, Ding EL, Kiel DP, Berry SD.

J Am Geriatr Soc. 2011 Jun;59(6):1019-31. doi: 10.1111/j.1532-5415.2011.03450.x.

10.

A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.

Gill SS, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp A, Shulman KI, Lee PE, Rochon PA.

Arch Intern Med. 2005 Apr 11;165(7):808-13.

PMID:
15824303
11.

Adverse events in patients receiving cholinesterase inhibitors due to dissimilar follow-up periods.

Chan M.

Arch Intern Med. 2009 Oct 12;169(18):1724; author reply 1724-5. doi: 10.1001/archinternmed.2009.347. No abstract available.

PMID:
19822833
12.

Risk of pneumonia in new users of cholinesterase inhibitors for dementia.

Lai EC, Wong MB, Iwata I, Zhang Y, Hsieh CY, Kao Yang YH, Setoguchi S.

J Am Geriatr Soc. 2015 May;63(5):869-76. doi: 10.1111/jgs.13380.

PMID:
25912671
13.

Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands.

Kröger E, Berkers M, Carmichael PH, Souverein P, van Marum R, Egberts T.

Am J Geriatr Pharmacother. 2012 Dec;10(6):373-80. doi: 10.1016/j.amjopharm.2012.11.002.

PMID:
23217530
14.

Effects of dementia on postoperative outcomes of older adults with hip fractures: a population-based study.

Seitz DP, Gill SS, Gruneir A, Austin PC, Anderson GM, Bell CM, Rochon PA.

J Am Med Dir Assoc. 2014 May;15(5):334-41. doi: 10.1016/j.jamda.2013.12.011.

PMID:
24524851
15.

Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System.

Sheffrin M, Miao Y, Boscardin WJ, Steinman MA.

J Am Geriatr Soc. 2015 Aug;63(8):1512-8. doi: 10.1111/jgs.13511.

16.

Anticholinergic Drug Burden in Persons with Dementia Taking a Cholinesterase Inhibitor: The Effect of Multiple Physicians.

Reppas-Rindlisbacher CE, Fischer HD, Fung K, Gill SS, Seitz D, Tannenbaum C, Austin PC, Rochon PA.

J Am Geriatr Soc. 2016 Mar;64(3):492-500. doi: 10.1111/jgs.14034.

17.

Anticholinesterase-induced symptoms improved by pacemaker implantation in patients with Alzheimer's disease: analysis of 6 cases.

Osmonov D, Özcan KS, Erdinler I, Altay S, Turkkan C, Yildirim E, Gurkan K.

Am J Alzheimers Dis Other Demen. 2012 Aug;27(5):311-4. doi: 10.1177/1533317512452040.

PMID:
22815079
18.

Cholinesterase inhibitors for dementia with Lewy bodies.

Wild R, Pettit T, Burns A.

Cochrane Database Syst Rev. 2003;(3):CD003672. Review.

PMID:
12917981
19.

Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.

Bordier P, Garrigue S, Barold SS, Bressolles N, Lanusse S, Clémenty J.

Europace. 2003 Oct;5(4):429-31.

Items per page

Supplemental Content

Support Center